Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19

Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. Critical care immunotherapy company CytoSorbents Corp....
Streetwise Reports | April 14, 2020 |

Valeo Pharma bringing to market drug undergoing clinical trials to improve survival of COVID-19

Valeo Pharma Inc. (CSE: VPH) is a fast-growing revenue generating specialty pharmaceutical company with a strong product portfolio and a robust product pipeline. Valeo Pharma Inc. (CSE: VPH) is a fully integrated specialty pharmaceutical company focused on in-lice...
James O'Rourke | May 22, 2020 |

Almonty, BYD, Royal Helium - developments of great importance

We live in a global business environment, though currently we seem detached due to the fight against the Corona Pandemic, business goes on and this too shall pass. Elon Musk is already preparing for the conquest of space with SpaceX and the fierce battle for market share in th...
Mario Hose | September 17, 2020 |

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon | September 27, 2023 |

Seplat Petroleum to Acquire Eland Oil & Gas

A glance at the deal is provided in a Pareto Securities report. In an Oct. 15 research report, Pareto Securities analyst Tom Erik Kristiansen reported that this morning, Seplat Petroleum Development Co. Plc (SEPL:LSE) offered to acquire Eland Oil & Gas Plc (ELA:LSE...
Streetwise Reports | October 18, 2019 |

Analyst: Energy Firm's Weak Q3/19 'Could Offer Attractive Buying Opportunity'

The factors at play in the company's recent quarterly output are provided in a Pareto Securities report. In an Oct. 18 research note, analyst Tom Erik Kristiansen reported that Pareto Securities expects Equinor ASA (EQNR:NYSE; EQNR:Oslo) to report a weak Q3/19, but ...
Streetwise Reports | October 23, 2019 |

'Huge Upside Potential' on Firm That Turns Plastic Waste into Synthetic Fuels

The rationale for investing in this company is provided in a Pareto Securities report. In a Dec. 2 research note, analyst Tom Erik Kristiansen reported that Pareto Securities initiated coverage on Quantafuel SA (QFUEL:NO) with a Buy rating and a NOK250 per share tar...
Streetwise Reports | December 6, 2019 |

A steady diet of plastic

People eating fish are advised to watch carefully for bones, but how about tiny pieces of plastic? For years it has been known that plastic breaks down into microscopic particles that are consumed by shellfish, fish and mammals higher up the food chain, presentin...
Richard (Rick) Mills | August 21, 2019 |
1 2 3 4 5 6 7 8 9 10 ...